The registry has been designed to evaluate the long-term safety and efficacy of CCM therapy in a real-world setting.
Description
This is a global, prospective and retrospective, multicenter, single-arm, observational study intended to include patients who will receive/have received CCM therapy with an Impulse Dynamics system, including future CCM technologies (e.g. CCM-D), for a follow-up period of at least 5 years.
Who can participate
Inclusion Criteria:
* Patients who have /will be implanted with Impulse Dynamics CCM technologies (e.g. CCM or CCM-D when available) as determined by investigators
* Willing and able to provide informed consent, including for use of data for research purposes (e.g. publication, sub-studies/sub-analyses)
Exclusion Criteria:
* Noncompliant patients (e.g. for follow-up visits, medication, etc.) as determined by investigators.
* Subjects with a mechanical tricuspid valve
БГ